Security key
45782T105
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)
CUSIP: 45782T105
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 5,623,690
- Total 13F value
- $12,725,267
- Share change
- -539,613
- Put/Call ratio
- 211%
- SEC-reported price per share
- $2.31
- Number of holders
- 78
- Value change
- -$10,010,248
- Number of buys
- 47
- Number of sells
- 37
- Shares outstanding
- 27,969,231
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
78
Top holders
10
INMB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Inmune Bio, Inc. SEC filings
Inmune Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45782T105
Recent filing periods:
Ownership snapshot
Top reported holders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HIGHBRIDGE CAPITAL MANAGE...
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 5.2%
13D/G row: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Showing 1-6 of 15 holder rows.
Quick read
HIGHBRIDGE CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 5.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HIGHBRIDGE CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
HIGHBRIDGE CAPITAL MANAGEMENT LLC
5.2%
CVI Investments, Inc.
4.9%
Praetorian PR LLC
3.4%
BlackRock, Inc.
3.4%
VANGUARD GROUP INC
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
5.2%
|
$3,359,664
1,454,400 shares
|
$0 | 30 Jun 2025 |
| CVI Investments, Inc. |
13D/G
|
4.9%
|
$3,225,404
1,396,279 shares
|
-$239,596 | 30 Jun 2025 |
| Praetorian PR LLC |
13F
13D/G
Company · Kupperman Harris
|
3.4%
from 13D/G
|
$6,755,650
865,000 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
3.4%
|
$7,406,707
948,362 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3%
|
$6,455,848
826,613 shares
|
— | 31 Mar 2025 |
| RAYMOND JAMES FINANCIAL INC |
13F
Company
|
1.4%
|
$2,983,740
382,041 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
5,623,690
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
81
Q2 2025 holders
78
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend